Joel Patrick Veldhouse, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3587 12th St, Wayland, MI 49348 Phone: 616-648-4933 |
News Archive
Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot.
The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
Diagnostic company HealthLinx Limited reports that initial analysis of part 1 of its multinational ovarian cancer biomarker study confirms a statistically significant increase in diagnostic performance of OvPlex™ over CA125 alone. Enhanced performance of OvPlex™ was also established specifically for early stage (Stage I-II) disease.
When Darin McCloud, 45 from Portsmouth, was told he did not qualify for a gastric bypass, he planned to get fatter to tip the scales at more than 133kg - the weight deemed necessary by his local NHS primary care trust. At present he is eating three-quarters of a loaf of bread, four packets of crisps and bacon rolls each day to put on the weight. He also has diabetes ad he believes that the surgery could get him off the insulin injections.
› Verified 1 days ago